Additionally, we found that the RNASE4 level was 0.30 ± 0.16 μg/g in the stools of patients with IBD, which was approximately 30% lower than in the control group (0.42 ± 0.27 μg/g; Fig. 7e). This evidence concerns the gene RNASE4 and inflammatory bowel disease.